{"ticker": {"uuid": "481fc3d6-b7b7-4030-ae0f-96b9bc76f08b", "symbol": "RMD", "name": "ResMed Inc.", "exchange": "ASX", "country": "AU", "sector": "Healthcare", "industry": "Medical Instruments & Supplies"}, "articles": [{"title": "ResMed (RMD) Stock May Be 31% Undervalued After Soft FY27 Outlook", "summary": "Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. ResMed stock has lagged over the past year, yet both the Discounted Cash Flow (DCF) intrinsic value estimate and the market multiples currently point to the shares trading at a discount to what the underlying cash flows may justify. ResMed has returned 26.3% over the past 3 years, which suggests that longer term holders have still seen gains despite the recent share price weakness. Recent pressure around a softer outlook and suspended ventilator sales can weigh on sentiment, while uncert", "url": "https://finance.yahoo.com/markets/stocks/articles/resmed-rmd-stock-may-31-101225136.html", "source_name": "finance.yahoo.com", "published_at": "2026-08-12T10:12:25+00:00", "published_display": "12 Aug 2026 10:12", "sentiment": "positive", "sentiment_pct": 64, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.397, "duplicate_count": 1, "topics": ["Discounted Cash Flow", "Earnings", "Free Cash Flow", "Future Cash Flows", "Intrinsic Value", "Medical Equipment"]}, {"title": "Is Recall-Hit Outlook and Bigger Payout Altering The Investment Case For ResMed (RMD)?", "summary": "In early August 2026, ResMed reported past fourth-quarter and full-year results showing higher sales and earnings, announced a 10% increase in its quarterly US$0.66 dividend, and confirmed completion of a long-running US$1.40 billions share buyback program. At the same time, management issued a softer fiscal 2027 outlook tied to suspended ventilator sales after an FDA Class 1 recall and ongoing cost pressures, sharpening investor focus on how resilient ResMed's broader sleep-health and digital platform story may be. Next, we'll examine how the ventilator sales suspension and softer fiscal 2027", "url": "https://finance.yahoo.com/markets/stocks/articles/recall-hit-outlook-bigger-payout-023350160.html", "source_name": "finance.yahoo.com", "published_at": "2026-08-12T02:33:50+00:00", "published_display": "12 Aug 2026 02:33", "sentiment": "neutral", "sentiment_pct": 44, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.218, "duplicate_count": 1, "topics": ["Dividends", "Earnings", "Fda Approval", "Inflation", "Share Buyback"]}, {"title": "Inogen Cuts 2026 Revenue Outlook as U.S. Channel Pressure Persists", "summary": "Inogen, Inc. INGN lowered its 2026 revenue outlook after second-quarter results showed continued U.S. channel pressure despite better profitability and international growth. The revision puts more focus on how quickly the company can adapt its commercial model. The key question is whether weaker direct sales and rentals mainly reflect a channel transition or a more persistent growth constraint. International demand, new products and cost control provide offsets, but execution remains important. Inogen's Guidance Cut Resets 2026 Expectations Inogen now expects 2026 revenues of $355 million to $", "url": "https://finance.yahoo.com/healthcare/articles/inogen-cuts-2026-revenue-outlook-162300728.html", "source_name": "finance.yahoo.com", "published_at": "2026-08-11T16:23:00+00:00", "published_display": "11 Aug 2026 16:23", "sentiment": "neutral", "sentiment_pct": 45, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.158, "duplicate_count": 1, "topics": ["Earnings", "Guidance", "Healthcare", "International Expansion"]}, {"title": "Should Investors Buy Inogen as Low Valuation Meets Execution Risk?", "summary": "Inogen, Inc. INGN trades at a steep sales-multiple discount even as second-quarter 2026 margins improved and international demand remained firm. The disconnect creates an interesting setup, but the operating recovery is not yet broad-based. Investors must weigh better cost control, expanding respiratory offerings and a debt-free balance sheet against persistent pressure in U.S. direct sales and rentals. That mix supports patience rather than a simple value-driven call. Inogen, Inc Price and ConsensusInogen, Inc Price and Consensus Inogen, Inc price-consensus-chart | Inogen, Inc Quote Inogen's ", "url": "https://finance.yahoo.com/markets/stocks/articles/investors-buy-inogen-low-valuation-162200792.html", "source_name": "finance.yahoo.com", "published_at": "2026-08-11T16:22:00+00:00", "published_display": "11 Aug 2026 16:22", "sentiment": "positive", "sentiment_pct": 83, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.258, "duplicate_count": 1, "topics": ["Balance Sheet", "Earnings", "International Sales", "Margins", "Respiratory", "Valuation"]}, {"title": "Resmed\u2019s stock falls by 7% on soft FY27 outlook", "summary": "Resmed's shares fell by around 7% after the company forecast a softer than expected fiscal year 2027 (FY27) outlook due to suspended ventilator sales, ongoing macro uncertainty and inflation across electronic components and freight. Releasing its FY26 and Q4 FY26 results concurrently, the California-based sleep apnoea specialist achieved revenues of around $5.65bn in FY26, denoting a year-over-year (YoY) uptick of 10%. Meanwhile, the company reported Q4 revenues of $1.46bn, indicative of a 9% uptick YoY. Resmed's CEO, Mick Farrell, highlighted that Q4's \"strong\" results reflected \"continued mo", "url": "https://finance.yahoo.com/healthcare/articles/resmed-stock-falls-7-soft-110857107.html", "source_name": "finance.yahoo.com", "published_at": "2026-08-10T11:08:57+00:00", "published_display": "10 Aug 2026 11:08", "sentiment": "negative", "sentiment_pct": 23, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.304, "duplicate_count": 1, "topics": ["Earnings", "Fda Approval", "Inflation", "Restructuring"]}, {"title": "US Stock Market Today: S&P 500 Futures Climb On Softer Jobs Data And Yields", "summary": "Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. The Morning Bull - US Market Morning Update Monday, Aug, 10 2026 US stock futures are pointing higher this morning, with the S&P 500 contracts up around 0.6%, as investors weigh softer US jobs data against falling bond yields and cooler inflation expectations. July nonfarm payrolls showed a small job loss of 23,000 and weaker wage growth, which signals a slowing job market and less pressure from pay rises. At the same time, the 10 year Treasury yield has d", "url": "https://finance.yahoo.com/markets/stocks/articles/us-stock-market-today-p-081128237.html", "source_name": "finance.yahoo.com", "published_at": "2026-08-10T08:11:28+00:00", "published_display": "10 Aug 2026 08:11", "sentiment": "negative", "sentiment_pct": 36, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.182, "duplicate_count": 1, "topics": ["Balance Sheet", "Earnings", "Guidance", "Inflation", "Price Target", "Tech"]}, {"title": "RMD Q2 Deep Dive: Margin Pressures Weigh Despite Product Momentum and Portfolio Shifts", "summary": "RMD Q2 Deep Dive: Margin Pressures Weigh Despite Product Momentum and Portfolio Shifts Medical device company ResMed (NYSE:RMD) met Wall Street's revenue expectations in Q2 CY2026, with sales up 8.6% year on year to $1.46 billion. Its non-GAAP profit of $2.95 per share was 2% above analysts' consensus estimates. Is now the time to buy RMD? Find out in our full research report (it's free). ResMed (RMD) Q2 CY2026 Highlights: Revenue: $1.46 billion vs analyst estimates of $1.46 billion (8.6% year-on-year growth, in line) Adjusted EPS: $2.95 vs analyst estimates of $2.89 (2% beat) Operating Margin", "url": "https://finance.yahoo.com/healthcare/articles/rmd-q2-deep-dive-margin-053322130.html", "source_name": "finance.yahoo.com", "published_at": "2026-08-10T05:33:22+00:00", "published_display": "10 Aug 2026 05:33", "sentiment": "negative", "sentiment_pct": 36, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.271, "duplicate_count": 1, "topics": ["Earnings", "Free Cash Flow", "Margins", "Medical Devices", "Revenue Growth"]}, {"title": "Stocks Settle Higher as a Weak Jobs Report Allays Rate Hike Fears", "summary": "The S&P 500 Index ($SPX) (SPY) closed up +0.62% on Friday, the Dow Jones Industrial Average ($DOWI) (DIA) closed up +0.28%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed up +1.19%. September E-mini S&P futures (ESU26) rose +0.55%, and September E-mini Nasdaq futures (NQU26) rose +1.17%. Stock indices settled higher on Friday amid strength in corporate earnings results and reduced Fed rate hike fears. Stock indices found support on Friday as bond yields fell after US July nonfarm payrolls unexpectedly declined and average hourly earnings rose less than expected, bolstering speculation that the ", "url": "https://www.nasdaq.com/articles/stocks-settle-higher-weak-jobs-report-allays-rate-hike-fears", "source_name": "nasdaq.com", "published_at": "2026-08-07T22:18:07+00:00", "published_display": "07 Aug 2026 22:18", "sentiment": "negative", "sentiment_pct": 41, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.096, "duplicate_count": 1, "topics": ["Cybersecurity", "Earnings", "Earnings Results", "Interest Rates", "Operating Income", "Price Target"]}], "by_tier": {"direct": [{"title": "ResMed (RMD) Stock May Be 31% Undervalued After Soft FY27 Outlook", "summary": "Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. ResMed stock has lagged over the past year, yet both the Discounted Cash Flow (DCF) intrinsic value estimate and the market multiples currently point to the shares trading at a discount to what the underlying cash flows may justify. ResMed has returned 26.3% over the past 3 years, which suggests that longer term holders have still seen gains despite the recent share price weakness. Recent pressure around a softer outlook and suspended ventilator sales can weigh on sentiment, while uncert", "url": "https://finance.yahoo.com/markets/stocks/articles/resmed-rmd-stock-may-31-101225136.html", "source_name": "finance.yahoo.com", "published_at": "2026-08-12T10:12:25+00:00", "published_display": "12 Aug 2026 10:12", "provider": "eodhd", "sentiment": "positive", "sentiment_pct": 64, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.397, "duplicate_count": 1, "topics": ["Discounted Cash Flow", "Earnings", "Free Cash Flow", "Future Cash Flows", "Intrinsic Value", "Medical Equipment"]}, {"title": "Is Recall-Hit Outlook and Bigger Payout Altering The Investment Case For ResMed (RMD)?", "summary": "In early August 2026, ResMed reported past fourth-quarter and full-year results showing higher sales and earnings, announced a 10% increase in its quarterly US$0.66 dividend, and confirmed completion of a long-running US$1.40 billions share buyback program. At the same time, management issued a softer fiscal 2027 outlook tied to suspended ventilator sales after an FDA Class 1 recall and ongoing cost pressures, sharpening investor focus on how resilient ResMed's broader sleep-health and digital platform story may be. Next, we'll examine how the ventilator sales suspension and softer fiscal 2027", "url": "https://finance.yahoo.com/markets/stocks/articles/recall-hit-outlook-bigger-payout-023350160.html", "source_name": "finance.yahoo.com", "published_at": "2026-08-12T02:33:50+00:00", "published_display": "12 Aug 2026 02:33", "provider": "eodhd", "sentiment": "neutral", "sentiment_pct": 44, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.218, "duplicate_count": 1, "topics": ["Dividends", "Earnings", "Fda Approval", "Inflation", "Share Buyback"]}, {"title": "Inogen Cuts 2026 Revenue Outlook as U.S. Channel Pressure Persists", "summary": "Inogen, Inc. INGN lowered its 2026 revenue outlook after second-quarter results showed continued U.S. channel pressure despite better profitability and international growth. The revision puts more focus on how quickly the company can adapt its commercial model. The key question is whether weaker direct sales and rentals mainly reflect a channel transition or a more persistent growth constraint. International demand, new products and cost control provide offsets, but execution remains important. Inogen's Guidance Cut Resets 2026 Expectations Inogen now expects 2026 revenues of $355 million to $", "url": "https://finance.yahoo.com/healthcare/articles/inogen-cuts-2026-revenue-outlook-162300728.html", "source_name": "finance.yahoo.com", "published_at": "2026-08-11T16:23:00+00:00", "published_display": "11 Aug 2026 16:23", "provider": "eodhd", "sentiment": "neutral", "sentiment_pct": 45, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.158, "duplicate_count": 1, "topics": ["Earnings", "Guidance", "Healthcare", "International Expansion"]}, {"title": "Should Investors Buy Inogen as Low Valuation Meets Execution Risk?", "summary": "Inogen, Inc. INGN trades at a steep sales-multiple discount even as second-quarter 2026 margins improved and international demand remained firm. The disconnect creates an interesting setup, but the operating recovery is not yet broad-based. Investors must weigh better cost control, expanding respiratory offerings and a debt-free balance sheet against persistent pressure in U.S. direct sales and rentals. That mix supports patience rather than a simple value-driven call. Inogen, Inc Price and ConsensusInogen, Inc Price and Consensus Inogen, Inc price-consensus-chart | Inogen, Inc Quote Inogen's ", "url": "https://finance.yahoo.com/markets/stocks/articles/investors-buy-inogen-low-valuation-162200792.html", "source_name": "finance.yahoo.com", "published_at": "2026-08-11T16:22:00+00:00", "published_display": "11 Aug 2026 16:22", "provider": "eodhd", "sentiment": "positive", "sentiment_pct": 83, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.258, "duplicate_count": 1, "topics": ["Balance Sheet", "Earnings", "International Sales", "Margins", "Respiratory", "Valuation"]}, {"title": "Resmed\u2019s stock falls by 7% on soft FY27 outlook", "summary": "Resmed's shares fell by around 7% after the company forecast a softer than expected fiscal year 2027 (FY27) outlook due to suspended ventilator sales, ongoing macro uncertainty and inflation across electronic components and freight. Releasing its FY26 and Q4 FY26 results concurrently, the California-based sleep apnoea specialist achieved revenues of around $5.65bn in FY26, denoting a year-over-year (YoY) uptick of 10%. Meanwhile, the company reported Q4 revenues of $1.46bn, indicative of a 9% uptick YoY. Resmed's CEO, Mick Farrell, highlighted that Q4's \"strong\" results reflected \"continued mo", "url": "https://finance.yahoo.com/healthcare/articles/resmed-stock-falls-7-soft-110857107.html", "source_name": "finance.yahoo.com", "published_at": "2026-08-10T11:08:57+00:00", "published_display": "10 Aug 2026 11:08", "provider": "eodhd", "sentiment": "negative", "sentiment_pct": 23, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.304, "duplicate_count": 1, "topics": ["Earnings", "Fda Approval", "Inflation", "Restructuring"]}, {"title": "US Stock Market Today: S&P 500 Futures Climb On Softer Jobs Data And Yields", "summary": "Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. The Morning Bull - US Market Morning Update Monday, Aug, 10 2026 US stock futures are pointing higher this morning, with the S&P 500 contracts up around 0.6%, as investors weigh softer US jobs data against falling bond yields and cooler inflation expectations. July nonfarm payrolls showed a small job loss of 23,000 and weaker wage growth, which signals a slowing job market and less pressure from pay rises. At the same time, the 10 year Treasury yield has d", "url": "https://finance.yahoo.com/markets/stocks/articles/us-stock-market-today-p-081128237.html", "source_name": "finance.yahoo.com", "published_at": "2026-08-10T08:11:28+00:00", "published_display": "10 Aug 2026 08:11", "provider": "eodhd", "sentiment": "negative", "sentiment_pct": 36, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.182, "duplicate_count": 1, "topics": ["Balance Sheet", "Earnings", "Guidance", "Inflation", "Price Target", "Tech"]}, {"title": "RMD Q2 Deep Dive: Margin Pressures Weigh Despite Product Momentum and Portfolio Shifts", "summary": "RMD Q2 Deep Dive: Margin Pressures Weigh Despite Product Momentum and Portfolio Shifts Medical device company ResMed (NYSE:RMD) met Wall Street's revenue expectations in Q2 CY2026, with sales up 8.6% year on year to $1.46 billion. Its non-GAAP profit of $2.95 per share was 2% above analysts' consensus estimates. Is now the time to buy RMD? Find out in our full research report (it's free). ResMed (RMD) Q2 CY2026 Highlights: Revenue: $1.46 billion vs analyst estimates of $1.46 billion (8.6% year-on-year growth, in line) Adjusted EPS: $2.95 vs analyst estimates of $2.89 (2% beat) Operating Margin", "url": "https://finance.yahoo.com/healthcare/articles/rmd-q2-deep-dive-margin-053322130.html", "source_name": "finance.yahoo.com", "published_at": "2026-08-10T05:33:22+00:00", "published_display": "10 Aug 2026 05:33", "provider": "eodhd", "sentiment": "negative", "sentiment_pct": 36, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.271, "duplicate_count": 1, "topics": ["Earnings", "Free Cash Flow", "Margins", "Medical Devices", "Revenue Growth"]}, {"title": "Stocks Settle Higher as a Weak Jobs Report Allays Rate Hike Fears", "summary": "The S&P 500 Index ($SPX) (SPY) closed up +0.62% on Friday, the Dow Jones Industrial Average ($DOWI) (DIA) closed up +0.28%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed up +1.19%. September E-mini S&P futures (ESU26) rose +0.55%, and September E-mini Nasdaq futures (NQU26) rose +1.17%. Stock indices settled higher on Friday amid strength in corporate earnings results and reduced Fed rate hike fears. Stock indices found support on Friday as bond yields fell after US July nonfarm payrolls unexpectedly declined and average hourly earnings rose less than expected, bolstering speculation that the ", "url": "https://www.nasdaq.com/articles/stocks-settle-higher-weak-jobs-report-allays-rate-hike-fears", "source_name": "nasdaq.com", "published_at": "2026-08-07T22:18:07+00:00", "published_display": "07 Aug 2026 22:18", "provider": "eodhd", "sentiment": "negative", "sentiment_pct": 41, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.096, "duplicate_count": 1, "topics": ["Cybersecurity", "Earnings", "Earnings Results", "Interest Rates", "Operating Income", "Price Target"]}], "industry": [], "sector": []}, "total_fetched": 8, "total_unique": 8, "total_relevant": 8, "pipeline_health": {"providers_attempted": 1, "providers_with_results": 1, "provider_counts": {"eodhd": 8}, "raw_articles": 8, "unique_stories": 8, "duplicates_removed": 0, "relevant_stories": 8, "current_evidence": 8, "direct_evidence": 8, "eodhd_articles": 8, "eodhd": {"configured": true, "status": "healthy", "calls_used": 265, "call_budget": 500, "budget_used_pct": 53.0, "requests_made": 53, "last_success_at": "2026-08-13T09:00:28.958981+00:00", "newest_seen_at": "2026-08-13T08:54:24+00:00", "rate_limit": 1200, "rate_remaining": 1199, "last_error": "", "mapped_mentions": 3292, "unmapped_mentions": 1927}, "status": "healthy"}, "sentiment_summary": {"positive": 2, "negative": 4, "neutral": 2, "score": 49, "raw_score": 48, "total": 8, "evidence_count": 8, "effective_articles": 7.03, "direct_story_count": 8, "industry_story_count": 0, "sector_story_count": 0, "story_count": 8, "source_count": 2, "source_concentration": 0.9037, "direct_share": 100, "dispersion": 19, "confidence": 74, "evidence_status": "measured", "score_version": "evidence-v4", "newest_article_at": "2026-08-12T10:12:25+00:00", "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "earnings", "primary_label": "Earnings", "confidence": 86, "events": [{"event": "earnings", "label": "Earnings", "weight": 4.2, "count": 7}, {"event": "capital_return", "label": "Capital return", "weight": 0.6, "count": 1}], "positive_events": 2, "negative_events": 4, "pipeline": {"providers_attempted": 1, "providers_with_results": 1, "provider_counts": {"eodhd": 8}, "raw_articles": 8, "unique_stories": 8, "duplicates_removed": 0, "relevant_stories": 8, "current_evidence": 8, "direct_evidence": 8, "eodhd_articles": 8, "eodhd": {"configured": true, "status": "healthy", "calls_used": 265, "call_budget": 500, "budget_used_pct": 53.0, "requests_made": 53, "last_success_at": "2026-08-13T09:00:28.958981+00:00", "newest_seen_at": "2026-08-13T08:54:24+00:00", "rate_limit": 1200, "rate_remaining": 1199, "last_error": "", "mapped_mentions": 3292, "unmapped_mentions": 1927}, "status": "healthy"}}, "market_context": {"has_market_context": true, "latest_close": 28.87, "latest_week": "2026-08-07", "one_week_move": -3.1, "four_week_move": -3.9, "twelve_week_move": 1.9, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.715059, "market_dynamics_buy_signal": false, "relative_strength": -21.702287, "fair_value_gap": -12.5, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "undecided", "expectation_probability": 45.2666, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-3.1% over one week, -3.9% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 57, "badges": [], "opportunities": [], "risks": [], "event_label": "Earnings", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "finance.yahoo.com", "count": 7}, {"label": "nasdaq.com", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 8}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Earnings", "count": 7}, {"label": "Capital return", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "49/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Evidence confidence", "value": "74/100", "tone": "positive", "text": "7.03 effective stories after overlap and weighting."}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Earnings", "tone": "neutral", "text": "86/100 classification confidence."}, {"label": "Company focus", "value": "8", "tone": "positive", "text": "100% of weighted evidence is company-specific."}, {"label": "Evidence agreement", "value": "19/100", "tone": "neutral", "text": "lower dispersion means the independent stories agree more closely."}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-3.1% over one week, -3.9% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Positive", "tone": "positive", "text": "ResMed (RMD) Stock May Be 31% Undervalued After Soft FY27 Outlook"}], "updated_at": "2026-08-13T09:12:16.107726+00:00", "detail_intelligence": {"headline": "Balanced read", "summary": "Balanced news tone is drawn from 8 fresh independent stories, including 8 company-specific items across 2 publishers.", "status": "measured", "metrics": [{"label": "Weighted tone", "value": 49, "display": "49", "tone": "neutral", "note": "Balanced news tone"}, {"label": "Evidence confidence", "value": 74, "display": "74", "tone": "positive", "note": "solid confidence"}, {"label": "Company focus", "value": 100, "display": "100%", "tone": "positive", "note": "8 direct stories"}, {"label": "Evidence agreement", "value": 81, "display": "81", "tone": "positive", "note": "19/100 dispersion"}], "confidence_drivers": [{"label": "Sample depth", "value": 88, "note": "7.03 effective stories"}, {"label": "Source breadth", "value": 40, "note": "2 independent publishers"}, {"label": "Direct relevance", "value": 100, "note": "company-specific evidence share"}, {"label": "Freshness", "value": 69, "note": "recency-weighted evidence"}, {"label": "Agreement", "value": 81, "note": "cross-story consistency"}, {"label": "Source independence", "value": 10, "note": "lower publisher concentration"}], "freshness": 69, "source_independence": 10, "timeline": [{"date": "2026-07-24", "label": "24 Jul", "count": 0, "score": null, "tone": "neutral", "x": 42.0, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-25", "label": "25 Jul", "count": 0, "score": null, "tone": "neutral", "x": 87.8, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-26", "label": "26 Jul", "count": 0, "score": null, "tone": "neutral", "x": 133.6, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-27", "label": "27 Jul", "count": 0, "score": null, "tone": "neutral", "x": 179.4, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-28", "label": "28 Jul", "count": 0, "score": null, "tone": "neutral", "x": 225.2, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-29", "label": "29 Jul", "count": 0, "score": null, "tone": "neutral", "x": 271.0, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-30", "label": "30 Jul", "count": 0, "score": null, "tone": "neutral", "x": 316.8, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-07-31", "label": "31 Jul", "count": 0, "score": null, "tone": "neutral", "x": 362.6, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-01", "label": "01 Aug", "count": 0, "score": null, "tone": "neutral", "x": 408.4, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-02", "label": "02 Aug", "count": 0, "score": null, "tone": "neutral", "x": 454.2, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-03", "label": "03 Aug", "count": 0, "score": null, "tone": "neutral", "x": 500.0, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-04", "label": "04 Aug", "count": 0, "score": null, "tone": "neutral", "x": 545.8, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-05", "label": "05 Aug", "count": 0, "score": null, "tone": "neutral", "x": 591.6, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-06", "label": "06 Aug", "count": 0, "score": null, "tone": "neutral", "x": 637.4, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-07", "label": "07 Aug", "count": 1, "score": 41, "tone": "negative", "x": 683.2, "y": 151.4, "volume_height": 17.3, "volume_y": 248.7}, {"date": "2026-08-08", "label": "08 Aug", "count": 0, "score": null, "tone": "neutral", "x": 729.0, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-09", "label": "09 Aug", "count": 0, "score": null, "tone": "neutral", "x": 774.8, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}, {"date": "2026-08-10", "label": "10 Aug", "count": 3, "score": 31, "tone": "negative", "x": 820.6, "y": 169.6, "volume_height": 52.0, "volume_y": 214.0}, {"date": "2026-08-11", "label": "11 Aug", "count": 2, "score": 69, "tone": "positive", "x": 866.4, "y": 100.4, "volume_height": 34.7, "volume_y": 231.3}, {"date": "2026-08-12", "label": "12 Aug", "count": 2, "score": 57, "tone": "neutral", "x": 912.2, "y": 122.3, "volume_height": 34.7, "volume_y": 231.3}, {"date": "2026-08-13", "label": "13 Aug", "count": 0, "score": null, "tone": "neutral", "x": 958.0, "y": 135.0, "volume_height": 0.0, "volume_y": 266.0}], "timeline_points": "683.2,151.4 820.6,169.6 866.4,100.4 912.2,122.3", "timeline_has_signal": true, "timeline_start": "24 Jul", "timeline_mid": "03 Aug", "timeline_end": "13 Aug", "momentum": {"label": "Improving", "tone": "positive", "recent_score": 53, "prior_score": 37, "delta": 16, "recent_count": 5, "prior_count": 3, "volume_delta": 2}, "freshness_buckets": [{"label": "Last 24 hours", "count": 1, "share": 12}, {"label": "1 to 3 days", "count": 4, "share": 50}, {"label": "4 to 7 days", "count": 3, "share": 38}, {"label": "8 to 30 days", "count": 0, "share": 0}], "source_profile": [{"label": "finance.yahoo.com", "count": 7, "share": 88, "score": 49, "tone": "neutral"}, {"label": "nasdaq.com", "count": 1, "share": 12, "score": 41, "tone": "negative"}], "event_profile": [{"label": "Earnings", "count": 7, "share": 88, "score": 49, "tone": "neutral"}, {"label": "Capital return", "count": 1, "share": 12, "score": 44, "tone": "neutral"}], "topics": [{"label": "Earnings", "count": 8, "share": 100}, {"label": "Inflation", "count": 3, "share": 38}, {"label": "Price Target", "count": 2, "share": 25}, {"label": "Margins", "count": 2, "share": 25}, {"label": "Guidance", "count": 2, "share": 25}, {"label": "Free Cash Flow", "count": 2, "share": 25}, {"label": "Fda Approval", "count": 2, "share": 25}, {"label": "Balance Sheet", "count": 2, "share": 25}, {"label": "Valuation", "count": 1, "share": 12}, {"label": "Tech", "count": 1, "share": 12}], "supporting": [{"label": "Direct evidence", "text": "8 current stories are mapped specifically to RMD."}, {"label": "Narrative agreement", "text": "Cross-story agreement is 81/100, indicating a comparatively coherent tape."}], "tempering": [{"label": "Source breadth", "text": "Only 2 publishers currently contribute to the measured read."}], "supporting_heading": "What supports the read", "tempering_heading": "What tempers the read", "latest_observation": {"title": "ResMed (RMD) Stock May Be 31% Undervalued After Soft FY27 Outlook", "summary": "Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. ResMed stock has lagged over the past year, yet both the Discounted Cash Flow (DCF) intrinsic value estimate and the market multiples currently point to the shares trading at a discount to what the underlying cash flows may justify. ResMed has returned 26.3% over the past 3 years, which suggests that longer term holders have still seen gains despite the recent share price weakness. Recent pressure around a softer outlook and suspended ventilator sales can weigh on sentiment, while uncert", "url": "https://finance.yahoo.com/markets/stocks/articles/resmed-rmd-stock-may-31-101225136.html", "source_name": "finance.yahoo.com", "published_at": "2026-08-12T10:12:25+00:00", "published_display": "12 Aug 2026 10:12", "sentiment": "positive", "sentiment_pct": 64, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage", "is_stale": false, "evidence_weight": 0.397, "duplicate_count": 1, "topics": ["Discounted Cash Flow", "Earnings", "Free Cash Flow", "Future Cash Flows", "Intrinsic Value", "Medical Equipment"]}, "article_count": 8, "updated_at": "2026-08-13T09:12:16.107726+00:00"}, "price_sentiment_path": {"available": true, "price_points": [{"x": 42.0, "y": 88.9, "label": "13 Feb 2026", "close": 34.1, "index": 100.0}, {"x": 78.6, "y": 55.8, "label": "20 Feb 2026", "close": 36.22, "index": 106.2}, {"x": 115.3, "y": 59.4, "label": "27 Feb 2026", "close": 35.99, "index": 105.6}, {"x": 151.9, "y": 58.3, "label": "06 Mar 2026", "close": 36.06, "index": 105.8}, {"x": 188.6, "y": 107.5, "label": "13 Mar 2026", "close": 32.9, "index": 96.5}, {"x": 225.2, "y": 120.5, "label": "20 Mar 2026", "close": 32.06, "index": 94.0}, {"x": 261.8, "y": 117.4, "label": "27 Mar 2026", "close": 32.26, "index": 94.6}, {"x": 298.5, "y": 119.3, "label": "03 Apr 2026", "close": 32.14, "index": 94.3}, {"x": 335.1, "y": 118.2, "label": "10 Apr 2026", "close": 32.21, "index": 94.5}, {"x": 371.8, "y": 130.0, "label": "17 Apr 2026", "close": 31.45, "index": 92.2}, {"x": 408.4, "y": 139.8, "label": "24 Apr 2026", "close": 30.82, "index": 90.4}, {"x": 445.0, "y": 173.3, "label": "01 May 2026", "close": 28.67, "index": 84.1}, {"x": 481.7, "y": 175.9, "label": "08 May 2026", "close": 28.5, "index": 83.6}, {"x": 518.3, "y": 178.5, "label": "15 May 2026", "close": 28.33, "index": 83.1}, {"x": 555.0, "y": 162.4, "label": "22 May 2026", "close": 29.37, "index": 86.1}, {"x": 591.6, "y": 172.0, "label": "29 May 2026", "close": 28.75, "index": 84.3}, {"x": 628.2, "y": 189.3, "label": "05 Jun 2026", "close": 27.64, "index": 81.1}, {"x": 664.9, "y": 188.0, "label": "12 Jun 2026", "close": 27.72, "index": 81.3}, {"x": 701.5, "y": 204.2, "label": "19 Jun 2026", "close": 26.68, "index": 78.2}, {"x": 738.2, "y": 169.0, "label": "26 Jun 2026", "close": 28.94, "index": 84.9}, {"x": 774.8, "y": 144.8, "label": "03 Jul 2026", "close": 30.5, "index": 89.5}, {"x": 811.4, "y": 152.1, "label": "10 Jul 2026", "close": 30.03, "index": 88.1}, {"x": 848.1, "y": 172.0, "label": "17 Jul 2026", "close": 28.75, "index": 84.3}, {"x": 884.7, "y": 192.5, "label": "24 Jul 2026", "close": 27.43, "index": 80.4}, {"x": 921.4, "y": 155.8, "label": "31 Jul 2026", "close": 29.79, "index": 87.4}, {"x": 958.0, "y": 170.1, "label": "07 Aug 2026", "close": 28.87, "index": 84.7}], "sentiment_points": [{"x": 709.3, "y": 126.3, "label": "20 Jun 2026", "score": 52}, {"x": 713.0, "y": 126.3, "label": "21 Jun 2026", "score": 52}, {"x": 718.5, "y": 124.5, "label": "22 Jun 2026", "score": 53}, {"x": 721.3, "y": 124.5, "label": "22 Jun 2026", "score": 53}, {"x": 721.7, "y": 124.5, "label": "22 Jun 2026", "score": 53}, {"x": 722.8, "y": 124.5, "label": "23 Jun 2026", "score": 53}, {"x": 733.6, "y": 120.8, "label": "25 Jun 2026", "score": 55}, {"x": 740.8, "y": 124.5, "label": "26 Jun 2026", "score": 53}, {"x": 742.6, "y": 124.5, "label": "26 Jun 2026", "score": 53}, {"x": 752.0, "y": 119.0, "label": "28 Jun 2026", "score": 56}, {"x": 759.1, "y": 119.0, "label": "29 Jun 2026", "score": 56}, {"x": 769.0, "y": 120.8, "label": "01 Jul 2026", "score": 55}, {"x": 771.4, "y": 119.0, "label": "02 Jul 2026", "score": 56}, {"x": 776.4, "y": 115.3, "label": "03 Jul 2026", "score": 58}, {"x": 778.3, "y": 117.1, "label": "03 Jul 2026", "score": 57}, {"x": 778.4, "y": 117.1, "label": "03 Jul 2026", "score": 57}, {"x": 781.2, "y": 119.0, "label": "04 Jul 2026", "score": 56}, {"x": 787.5, "y": 117.1, "label": "05 Jul 2026", "score": 57}, {"x": 801.5, "y": 119.0, "label": "08 Jul 2026", "score": 56}, {"x": 802.9, "y": 124.5, "label": "08 Jul 2026", "score": 53}, {"x": 803.6, "y": 124.5, "label": "08 Jul 2026", "score": 53}, {"x": 814.7, "y": 126.3, "label": "10 Jul 2026", "score": 52}, {"x": 839.1, "y": 120.8, "label": "15 Jul 2026", "score": 55}, {"x": 861.9, "y": 124.5, "label": "19 Jul 2026", "score": 53}, {"x": 862.5, "y": 122.6, "label": "19 Jul 2026", "score": 54}, {"x": 881.1, "y": 120.8, "label": "23 Jul 2026", "score": 55}, {"x": 882.0, "y": 117.1, "label": "23 Jul 2026", "score": 57}, {"x": 882.7, "y": 120.8, "label": "23 Jul 2026", "score": 55}, {"x": 903.0, "y": 124.5, "label": "27 Jul 2026", "score": 53}, {"x": 904.3, "y": 124.5, "label": "27 Jul 2026", "score": 53}, {"x": 911.3, "y": 117.1, "label": "29 Jul 2026", "score": 57}, {"x": 913.3, "y": 120.8, "label": "29 Jul 2026", "score": 55}, {"x": 913.6, "y": 119.0, "label": "29 Jul 2026", "score": 56}, {"x": 929.9, "y": 117.1, "label": "01 Aug 2026", "score": 57}, {"x": 930.0, "y": 117.1, "label": "01 Aug 2026", "score": 57}, {"x": 930.1, "y": 117.1, "label": "01 Aug 2026", "score": 57}, {"x": 931.5, "y": 117.1, "label": "01 Aug 2026", "score": 57}, {"x": 932.8, "y": 119.0, "label": "02 Aug 2026", "score": 56}, {"x": 940.3, "y": 122.6, "label": "03 Aug 2026", "score": 54}, {"x": 940.8, "y": 122.6, "label": "03 Aug 2026", "score": 54}, {"x": 947.7, "y": 120.8, "label": "05 Aug 2026", "score": 55}, {"x": 947.9, "y": 120.8, "label": "05 Aug 2026", "score": 55}, {"x": 956.3, "y": 120.8, "label": "06 Aug 2026", "score": 55}], "price_path": "42.0,88.9 78.6,55.8 115.3,59.4 151.9,58.3 188.6,107.5 225.2,120.5 261.8,117.4 298.5,119.3 335.1,118.2 371.8,130.0 408.4,139.8 445.0,173.3 481.7,175.9 518.3,178.5 555.0,162.4 591.6,172.0 628.2,189.3 664.9,188.0 701.5,204.2 738.2,169.0 774.8,144.8 811.4,152.1 848.1,172.0 884.7,192.5 921.4,155.8 958.0,170.1", "sentiment_path": "709.3,126.3 713.0,126.3 718.5,124.5 721.3,124.5 721.7,124.5 722.8,124.5 733.6,120.8 740.8,124.5 742.6,124.5 752.0,119.0 759.1,119.0 769.0,120.8 771.4,119.0 776.4,115.3 778.3,117.1 778.4,117.1 781.2,119.0 787.5,117.1 801.5,119.0 802.9,124.5 803.6,124.5 814.7,126.3 839.1,120.8 861.9,124.5 862.5,122.6 881.1,120.8 882.0,117.1 882.7,120.8 903.0,124.5 904.3,124.5 911.3,117.1 913.3,120.8 913.6,119.0 929.9,117.1 930.0,117.1 930.1,117.1 931.5,117.1 932.8,119.0 940.3,122.6 940.8,122.6 947.7,120.8 947.9,120.8 956.3,120.8", "price_change": -15.3, "sentiment_change": 3, "latest_close": 28.87, "start_label": "13 Feb", "mid_label": "15 May", "end_label": "07 Aug"}, "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}